Brain training may sharpen memory in early Alzheimer's risk
NCT ID NCT04566900
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a computer-based brain-training program called neurofeedback in 112 people with mild cognitive impairment, an early stage of Alzheimer's disease. Participants learn to control their brain activity through visual or audio cues, aiming to improve working memory. The goal is to see if this approach can slow cognitive decline and provide a foundation for larger future trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
neurofeedback (brain-training program)
What this could lead to
If it works, this could offer a non-drug way to improve memory and potentially slow the transition from mild cognitive impairment to Alzheimer's disease.
What could go wrong
This is an early-stage study with only 112 participants, and the benefits may be small or not last long. The placebo group also gets a similar experience, so the real effect may be unclear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California at San Diego
La Jolla, California, 92093, United States